List of works by Jonathan A Fallowfield

A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP)

scientific article published on 12 March 2020

Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography

scientific article published on 15 June 2017

Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study

scientific article published on 20 May 2020

Editorial: getting bullish about portal hypertension-chronic treatment with oral taurine?

scientific article published in February 2018

In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.

scientific article published on 7 September 2017

Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study.

scientific article

Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study

scientific article published on 02 July 2018

Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh Type 2 Diabetes Study

scientific article published on 07 July 2020

Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer

scientific article published on 02 December 2020

Resolving the fibrotic niche of human liver cirrhosis at single-cell level

scientific article published on 09 October 2019

Safety profile of autologous macrophage therapy for liver cirrhosis

scientific article published on 07 October 2019

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial

scientific article

The Eye as a Non-Invasive Window to the Microcirculation in Liver Cirrhosis: A Prospective Pilot Study

scientific article published on 17 October 2020

Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease.

scientific article published on 22 December 2017